GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cytrx Corporation (CYTR) [hlAlert]

Rating:
Buy CYTR
down 55.80 %

Cytrx Corporation (CYTR) rated Buy with price target $2 by Brean Murray

Posted on: Tuesday,  Mar 3, 2009  11:25 AM ET by Brean Murray

Brean Murray rated Buy Cytrx Corporation (NASDAQ: CYTR) on 03/03/2009. Previously Brean Murray rated Buy Cytrx Corporation (NASDAQ: CYTR) on 06/12/2008.,
when the stock price was $5.25. Since then, Cytrx Corporation has lost 55.81% as of 01/26/2016's recent price of $2.32.
If you would have followed the previous Brean Murray's recommendation on CYTR, you would have lost 55.8% of your investment in 2784 days.

CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2009 11:25 AM Buy
None
2.04 14.00
as of 12/31/2009
1 Week down  -28.20 %
1 Month down  -12.50 %
3 Months down  -25.00 %
1 YTD up  180.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/12/2008 8:25 AM Buy
None
5.25 21.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy